Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
LivaNova PLC stock logo
LIVN
LivaNova
$46.04
-1.3%
$40.34
$32.48
$57.35
$2.50B0.9642,470 shs118,895 shs
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
$6.05
-1.1%
$6.75
$5.47
$10.14
$889.91M1.82684,573 shs509,634 shs
Envista Holdings Co. stock logo
NVST
Envista
$18.48
-2.1%
$17.02
$14.22
$23.00
$3.13B0.992.56 million shs759,497 shs
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$60.19
-1.6%
$55.99
$47.04
$103.81
$3.32B1.1835,271 shs271,966 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
LivaNova PLC stock logo
LIVN
LivaNova
-0.15%+3.97%+5.83%+18.83%-11.70%
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
-4.67%-3.47%-14.64%-22.73%-14.53%
Envista Holdings Co. stock logo
NVST
Envista
-1.74%+0.99%+0.91%+13.50%+3.85%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-1.55%-5.98%+15.31%+6.14%-6.84%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
LivaNova PLC stock logo
LIVN
LivaNova
3.1975 of 5 stars
3.54.00.00.02.21.71.3
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
3.8169 of 5 stars
3.53.00.00.02.93.31.9
Envista Holdings Co. stock logo
NVST
Envista
3.4199 of 5 stars
2.22.00.03.82.70.01.9
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
1.9349 of 5 stars
3.41.00.00.01.42.50.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
LivaNova PLC stock logo
LIVN
LivaNova
3.00
Buy$59.2928.77% Upside
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
3.00
Buy$12.50106.61% Upside
Envista Holdings Co. stock logo
NVST
Envista
2.33
Hold$20.239.46% Upside
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
2.86
Moderate Buy$90.0049.53% Upside

Current Analyst Ratings Breakdown

Latest MDXG, PRCT, NVST, and LIVN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/27/2025
Envista Holdings Co. stock logo
NVST
Envista
Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
5/27/2025
Envista Holdings Co. stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Outperform$21.00 ➝ $23.00
5/20/2025
LivaNova PLC stock logo
LIVN
LivaNova
Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradePeer Perform ➝ Outperform$60.00
5/13/2025
LivaNova PLC stock logo
LIVN
LivaNova
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$64.00 ➝ $64.00
5/8/2025
LivaNova PLC stock logo
LIVN
LivaNova
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$56.00 ➝ $55.00
5/8/2025
LivaNova PLC stock logo
LIVN
LivaNova
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$55.00 ➝ $61.00
5/5/2025
Envista Holdings Co. stock logo
NVST
Envista
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$21.00 ➝ $18.00
5/2/2025
Envista Holdings Co. stock logo
NVST
Envista
Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$21.00
4/30/2025
Envista Holdings Co. stock logo
NVST
Envista
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$18.00 ➝ $17.00
4/29/2025
Envista Holdings Co. stock logo
NVST
Envista
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$26.00 ➝ $23.00
4/25/2025
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$104.00 ➝ $84.00
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
LivaNova PLC stock logo
LIVN
LivaNova
$1.28B1.97$4.13 per share11.15$23.72 per share1.94
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
$352.38M2.54$0.14 per share41.75$0.98 per share6.17
Envista Holdings Co. stock logo
NVST
Envista
$2.50B1.25$1.43 per share12.91$17.04 per share1.08
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
$249.12M13.37N/AN/A$5.56 per share10.83
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
LivaNova PLC stock logo
LIVN
LivaNova
$17.55M-$4.09109.3814.66N/A1.91%13.81%7.07%7/30/2025 (Estimated)
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
$58.23M$0.2710.9518.91N/A23.86%26.21%18.15%7/30/2025 (Estimated)
Envista Holdings Co. stock logo
NVST
Envista
-$1.12B-$6.53N/A15.281.27-44.56%3.86%2.21%8/6/2025 (Estimated)
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$105.90M-$1.70N/AN/AN/A-50.07%-38.57%-26.06%7/30/2025 (Estimated)

Latest MDXG, PRCT, NVST, and LIVN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025
Envista Holdings Co. stock logo
NVST
Envista
$0.20$0.24+$0.04$0.10$608.17 million$616.90 million
4/30/2025Q1 2025
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
$0.06$0.06N/A$0.05$86.32 million$88.21 million
4/24/2025Q1 2025
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
-$0.49-$0.45+$0.04-$0.45$65.39 million$69.16 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
LivaNova PLC stock logo
LIVN
LivaNova
N/AN/AN/AN/AN/A
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
N/AN/AN/AN/AN/A
Envista Holdings Co. stock logo
NVST
Envista
N/AN/AN/AN/AN/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
LivaNova PLC stock logo
LIVN
LivaNova
0.46
3.37
2.87
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
0.10
4.10
3.53
Envista Holdings Co. stock logo
NVST
Envista
0.44
2.04
1.76
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
0.21
6.02
5.07

Institutional Ownership

CompanyInstitutional Ownership
LivaNova PLC stock logo
LIVN
LivaNova
97.64%
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
79.15%
Envista Holdings Co. stock logo
NVST
Envista
N/A
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
89.46%

Insider Ownership

CompanyInsider Ownership
LivaNova PLC stock logo
LIVN
LivaNova
0.29%
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
1.70%
Envista Holdings Co. stock logo
NVST
Envista
1.30%
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
6.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
LivaNova PLC stock logo
LIVN
LivaNova
2,90054.53 million54.15 millionOptionable
MiMedx Group, Inc. stock logo
MDXG
MiMedx Group
870147.70 million145.04 millionOptionable
Envista Holdings Co. stock logo
NVST
Envista
12,700169.49 million169.95 millionOptionable
PROCEPT BioRobotics Co. stock logo
PRCT
PROCEPT BioRobotics
43055.33 million43.10 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

LivaNova stock logo

LivaNova NASDAQ:LIVN

$46.04 -0.59 (-1.27%)
As of 02:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products. The Neuromodulation segment designs, develops, markets, and sells VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; difficult-to-treat depression and drug-resistant epilepsy devices. The Advanced Circulatory Support segment develops, produces, and sells temporary life support products. It serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers. The company sells its products through direct sales representatives and independent distributors. LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.

MiMedx Group stock logo

MiMedx Group NASDAQ:MDXG

$6.05 -0.07 (-1.14%)
As of 02:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary processing method employs aseptic processing techniques in addition to terminal sterilization. Its products include EpiFix, a barrier membrane allograft used for the treatment of chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; AmnioFix, a protective barrier allograft, which comprises dehydrated human amnion/chorion membrane for use in surgical recovery applications; and EpiCord and AmnioCord are dehydrated human umbilical cord allografts that are used to provide a protective environment for the healing process, as well as used in the advanced wound care and surgical recovery applications. The company's products have applications in the areas of wound care, burn, surgical sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. MiMedx Group, Inc. was founded in 2006 and is headquartered in Marietta, Georgia.

Envista stock logo

Envista NYSE:NVST

$18.48 -0.39 (-2.05%)
As of 02:47 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

PROCEPT BioRobotics stock logo

PROCEPT BioRobotics NASDAQ:PRCT

$60.19 -0.97 (-1.59%)
As of 02:46 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.